Patents by Inventor Shawn Bauer

Shawn Bauer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tetrahydroisoquinolines as factor Xa inhibitors
    Patent number: 7612089
    Abstract: The present invention is directed to compounds represented by Formula I and pharmaceutically acceptable salts, solvates, hydrates, and prodrugs thereof which are inhibitors of Factor Xa. The present invention is also directed to and intermediates used in making such compounds, pharmaceutical compositions containing such compounds, methods to prevent or treat a number of conditions characterized by undesired thrombosis and methods of inhibiting the coagulation of a blood sample.
    Type: Grant
    Filed: November 21, 2005
    Date of Patent: November 3, 2009
    Assignee: Portola Pharmaceuticals, Inc.
    Inventors: Yonghong Song, Bing-Yan Zhu, Shumei Wang, Shawn Bauer, Robert M. Scarborough
  • Benzamide inhibitors of factor Xa
    Patent number: 7312235
    Abstract: Novel benzamide compounds, their salts and compositions related thereto having activity against mammalian Factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or treating coagulation disorders.
    Type: Grant
    Filed: April 1, 2002
    Date of Patent: December 25, 2007
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Bing-Yan Zhu, Penglie Zhang, Erick A. Goldman, Zhaozhong Jon Jia, Shawn Bauer, Wenrong Huang, John Woolfrey, Robert M. Scarborough
  • FACTOR Xa INHIBITORS
    Publication number: 20070185092
    Abstract: The present invention is directed to compounds represented by Formula (I) or a pharmaceutically acceptable salt, ester, or prodrug thereof which are inhibitors of Factor Xa. The present invention is also directed to and intermediates used in making such compounds, pharmaceutical compositions containing such compounds, methods to prevent or treat a number of conditions characterized by undesired thrombosis and methods of inhibiting the coagulation of a blood sample.
    Type: Application
    Filed: January 5, 2007
    Publication date: August 9, 2007
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Bing-Yan Zhu, Shawn Bauer, Zhaozhong Jia, Yonghong Song, Gary Probst, Yanchen Zhang, Robert Scarborough
  • Tetrahydroisoquinolines as factor Xa inhibitors
    Publication number: 20060160840
    Abstract: The present invention is directed to compounds represented by Formula I and pharmaceutically acceptable salts, solvates, hydrates, and prodrugs thereof which are inhibitors of Factor Xa. The present invention is also directed to and intermediates used in making such compounds, pharmaceutical compositions containing such compounds, methods to prevent or treat a number of conditions characterized by undesired thrombosis and methods of inhibiting the coagulation of a blood sample.
    Type: Application
    Filed: November 21, 2005
    Publication date: July 20, 2006
    Applicant: Portola Pharmaceuticals, Inc.
    Inventors: Yonghong Song, Bing-Yan Zhu, Shumei Wang, Shawn Bauer, Robert Scarborough
  • Factor Xa inhibitors
    Publication number: 20060100193
    Abstract: The present invention is directed to compounds represented by Formula I and pharmaceutically acceptable salts, solvates, hydrates, and prodrugs thereof which are inhibitors of Factor Xa. The present invention is also directed to and intermediates used in making such compounds, pharmaceutical compositions containing such compounds, methods to prevent or treat a number of conditions characterized by undesired thrombosis and methods of inhibiting the coagulation of a blood sample.
    Type: Application
    Filed: June 20, 2005
    Publication date: May 11, 2006
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Bing-Yan Zhu, Shawn Bauer, Zhaozhong Jia, Gary Probst, Yanchen Zhang, Robert Scarborough
  • 2,4-dioxo-3-quinazolinylaryl sulfonylureas
    Publication number: 20050107357
    Abstract: 2,4-Dioxo-3-quinazolinylaryl sulfonylurea compounds are provided that are useful for the inhibition of ADP-platelet aggregation, particularly in the treatment of thrombosis and thrombosis related conditions or disorders.
    Type: Application
    Filed: September 29, 2004
    Publication date: May 19, 2005
    Applicant: Portola Pharmaceuticals, Inc.
    Inventors: Robert Scarborough, Wolin Huang, Anjali Pandey, Shawn Bauer, Xiaoming Zhang, Zhaozhong Jia
  • Benzamide inhibitors of factor Xa
    Publication number: 20030069250
    Abstract: Novel benzamide compounds, their salts and compositions related thereto having activity against mammalian Factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or treating coagulation disorders.
    Type: Application
    Filed: April 1, 2002
    Publication date: April 10, 2003
    Inventors: Bing-Yan Zhu, Penglie Zhang, Erick A. Goldman, Zhaozhong Jon Jia, Shawn Bauer, Wenrong Huang, John Woolfrey, Robert M. Scarborough